InsiderClue
Insiders · Profile

Rosenberg Noah L.

CMO at Verrica Pharmaceuticals · Chief Medical Officer at Travere Therapeutics. Filing since 30 Jul 2019. CIK 0001579649

VRCA Verrica Pharmaceuticals Inc. CMO · 3 trades TVTX Travere Therapeutics, Inc. Chief Medical Officer · 15 trades
Company
Date
Role
Action
Shares
Amount
Of holding
VRCA Verrica Pharmaceuticals Inc.
18 Aug 2026
CMO
Bought
2,030
$9.99K
31.0%
VRCA Verrica Pharmaceuticals Inc.
17 Aug 2026
CMO
Bought
4,200
$20.62K
178%
VRCA Verrica Pharmaceuticals Inc.
25 Nov 2025
CMO
Bought
2,357
$10.00K
opened
TVTX Travere Therapeutics, Inc.
17 Aug 2021
Chief Medical Officer
Sold, plan not stated
1,407
$24.09K
2.9%
TVTX Travere Therapeutics, Inc.
28 Jul 2021
Chief Medical Officer
Sold, plan not stated
1,250
$17.26K
2.7%
TVTX Travere Therapeutics, Inc.
12 May 2021
Chief Medical Officer
Sold, plan not stated
375
$7.30K
0.8%
TVTX Travere Therapeutics, Inc.
11 May 2021
Chief Medical Officer
Sold, plan not stated
375
$7.18K
0.8%
TVTX Travere Therapeutics, Inc.
8 Feb 2021
Chief Medical Officer
Sold, plan not stated
1,125
$35.53K
2.4%
TVTX Travere Therapeutics, Inc.
5 Feb 2021
Chief Medical Officer
Sold, plan not stated
1,125
$35.34K
2.3%
TVTX Travere Therapeutics, Inc.
3 Feb 2021
Chief Medical Officer
Sold, plan not stated
1,813
$52.41K
3.9%
TVTX Travere Therapeutics, Inc.
2 Feb 2021
Chief Medical Officer
Sold, plan not stated
1,813
$55.75K
3.8%
TVTX Travere Therapeutics, Inc.
23 Sep 2020
Chief Medical Officer
Sold, plan not stated
750
$13.86K
2.6%
TVTX Travere Therapeutics, Inc.
22 Sep 2020
Chief Medical Officer
Sold, plan not stated
750
$13.94K
2.6%
TVTX Travere Therapeutics, Inc.
28 Jul 2020
Chief Medical Officer
Sold, plan not stated
870
$17.83K
3.2%
TVTX Travere Therapeutics, Inc.
12 May 2020
Chief Medical Officer
Sold, plan not stated
527
$8.95K
1.9%
TVTX Travere Therapeutics, Inc.
5 Mar 2020
Chief Medical Officer
Sold, plan not stated
1,790
$27.49K
6.2%
TVTX Travere Therapeutics, Inc.
31 Jul 2019
Chief Medical Officer
Sold, plan not stated
1,250
$25.09K
8.5%
TVTX Travere Therapeutics, Inc.
30 Jul 2019
Chief Medical Officer
Sold, plan not stated
1,250
$24.78K
7.8%
18 decisions on file.